Cargando…

Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma

AIM OF THE STUDY: To assess the serum levels of soluble toll-like receptor 2 (sTLR2) and soluble toll-like receptor 4 (sTLR4) in a group of patients with non-Hodgkin lymphoma (NHL) and to investigate their correlations with the clinicopathological parameters of NHL. MATERIAL AND METHODS: Fifty patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhry, Nouran, Gowily, Ahmed, Okda, Tarek, Houssen, Maha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670186/ https://www.ncbi.nlm.nih.gov/pubmed/33235541 http://dx.doi.org/10.5114/wo.2020.100270

Ejemplares similares

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients
por: Elkammah, Maha, et al.
Publicado: (2021)

Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer
por: El-Kharashy, Ghada, et al.
Publicado: (2021)

Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer
por: Wei, Feng, et al.
Publicado: (2016)

Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian Patients
por: Moaz, Inas, et al.
Publicado: (2023)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

Primary adrenal Hodgkin lymphoma
por: Haykal, Tarek, et al.
Publicado: (2019)

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
por: Hossain, Md Jakir, et al.
Publicado: (2018)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

Reed Sternberg-Like Cells in Non-Hodgkin Lymphoma: A Diagnostic Challenge
por: Yadav, Geeta, et al.
Publicado: (2022)

High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma
por: Guo, Xiaofang, et al.
Publicado: (2018)

Prognostic Significance of Serum Proangiogenic Molecules in Patients with De Novo Non-Hodgkin Lymphomas
por: Rujirojindakul, Pairaya, et al.
Publicado: (2012)

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Primary Pulmonary Hodgkin Lymphoma
por: Tanveer, Shumaila, et al.
Publicado: (2015)

The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers
por: Ahmed, Rehana, et al.
Publicado: (2022)

Hodgkin Lymphoma: Biology and Differential Diagnostic Problem
por: Takahara, Taishi, et al.
Publicado: (2022)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
por: Gronowitz, J. S., et al.
Publicado: (1983)

The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
por: Zhou, Min, et al.
Publicado: (2012)

Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2021)

Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia
por: Sachan, Rekha, et al.
Publicado: (2016)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

A Diagnostic Surprise: Primary Hodgkin’s Lymphoma of the Lung
por: Sinha, Ankur, et al.
Publicado: (2017)

Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients
por: Varnum, Susan M., et al.
Publicado: (2011)

Sarcoid-like reaction: Hodgkin’s lymphoma is a hypothesis
por: Oliveira, Cristiano Claudino
Publicado: (2020)

iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma
por: Yu, Runhong, et al.
Publicado: (2022)

Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma
por: Lennerz, Jochen K., et al.
Publicado: (2015)

Serum atrial natriuretic peptide: a suspected biomarker of breast cancer
por: Houssen, Maha E., et al.
Publicado: (2017)

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?
por: Child, J. A.
Publicado: (1991)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023)

Diagnostic Interval in Extranodal Non-Hodgkin Head and Neck Lymphomas
por: Castro, Alba Bello, et al.
Publicado: (2022)

Soluble and EV-Associated Diagnostic and Prognostic Biomarkers in Knee Osteoarthritis Pathology and Detection
por: Moravek, Marko, et al.
Publicado: (2023)

PB2254: TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA
por: Ali, Nesreen, et al.
Publicado: (2023)

Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma
por: Papoudou-Bai, Alexandra, et al.
Publicado: (2018)

Diagnostic and Prognostic Relevance of Bone Marrow Microenvironment Components in Non Hodgkin’s Lymphoma Cases Before and After Therapy
por: Soliman, Amira H
Publicado: (2016)

Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever
por: Kanda, Naoki, et al.
Publicado: (2023)

The Need for an Early Biomarker of Cardiovascular Disease in Survivors of Hodgkin Lymphoma
por: Ness, Kirsten K.
Publicado: (2021)

Hodgkin’s-like lymphoma in a ferret (Mustela putorius furo)
por: MATSUMOTO, Isao, et al.
Publicado: (2017)

Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component
por: Brigotti, Maurizio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s5q9lfa81tlk3bkr3tlb9ee8om